| 产品描述: | 4i is a 5-HT3 receptor antagonist,It modulates the serotonergic system. |
| 靶点: |
5-HT Receptor |
| 体内研究: |
5-HT3 拮抗剂 4 (4i)(0.5 和 1mg/kg/天,腹腔注射;持续 4 周)可改善糖尿病小鼠的糖尿病诱发的抑郁样行为和血清素缺乏。 |
| 参考文献: |
1. Deepali Gupta, et al. A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system. Behav Brain Res. 2016 Jan 15;297:41-50. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.359 ml |
16.793 ml |
33.586 ml |
| 5 mM |
0.672 ml |
3.359 ml |
6.717 ml |
| 10 mM |
0.336 ml |
1.679 ml |
3.359 ml |
| 50 mM |
0.067 ml |
0.336 ml |
0.672 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |